Prospect Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$477K Sell
519
-29
-5% -$29.4K 0.44% 39
2025
Q4
$589K Sell
548
-14
-2% -$13.4K 0.55% 37
2025
Q3
$429K Buy
562
+25
+5% +$18.6K 0.42% 39
2025
Q2
$419K Buy
537
+61
+13% +$47.4K 0.44% 37
2025
Q1
$393K Buy
476
+25
+6% +$20.8K 0.5% 38
2024
Q4
$348K Buy
+451
New +$373K 0.43% 39

Other funds holding LLY

Prospect Financial Group's LLY Position: Q1 2026 in Review

Prospect Financial Group reduced its Eli Lilly (LLY) stake by 5.3% in Q1 2026, selling an estimated $29.4K and leaving 519 shares worth $477K. The position accounts for 0.44% of the portfolio, ranked #39.

Prospect Financial Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $589K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prospect Financial Group held 519 shares of Eli Lilly worth $477K as of Q1 2026.
  • Prospect Financial Group sold 29 Eli Lilly shares in Q1 2026, an estimated $29.4K.
  • Eli Lilly made up 0.44% of Prospect Financial Group's portfolio in Q1 2026, its #39 holding.
  • Prospect Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Prospect Financial Group's Eli Lilly position peaked at $589K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prospect Financial Group's 13F filing for Q1 2026, filed 6 May 2026.